0001209191-23-058477.txt : 20231213
0001209191-23-058477.hdr.sgml : 20231213
20231213162112
ACCESSION NUMBER: 0001209191-23-058477
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231010
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosen Howard B
CENTRAL INDEX KEY: 0001307068
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 231484229
MAIL ADDRESS:
STREET 1: C/O ACELRX PHARMACEUTICALS, INC.
STREET 2: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 1850 GATEWAY DRIVE
STREET 2: SUITE 175
CITY: SAN MATEO
STATE: CA
ZIP: 94404
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-10
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001307068
Rosen Howard B
C/O ACELRX PHARMACEUTICALS, INC.
1850 GATEWAY DRIVE, SUITE 175
SAN MATEO
CA
94404
1
0
0
0
0
Common Stock
2023-10-10
4
A
0
581
0.00
A
5293
D
Stock Option (Right to Buy)
0.684
2023-10-10
4
A
0
3487
0.00
A
2024-10-10
2033-10-10
Common Stock
3487
3487
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
Effective on October 25, 2022, the issuer effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
100% of the option shares subject to the option shall vest on the first anniversary of the grant date, subject to Reporting Person's continuous service to the Company.
/s/ Martha Adler, Attorney-In-Fact
2023-12-13